FDA warning letter · Drugs

Shoolin Pharma Chem LLP

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure to clean, store, and sanitize equipment and utensils to prevent contamination or carry-over of a material that would alter the quality of the API beyond the official or other established specifications.

Passage 2

Failure to have laboratory control records that include complete data derived from all laboratory tests conducted to ensure your API complies with established specifications and standards.

Passage 3

Failure to design a documented, ongoing stability testing program to monitor the stability characteristics of API and to use the results to confirm appropriate storage conditions and retest or expiry dates.

Passage 4

Failure of your quality unit to exercise its responsibility to ensure the API manufactured at your facility are in compliance with CGMP.